Mobile

A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 888 Administered Intravenously in Sub...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-001281-86

A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 888 Administered Intravenously in Subjects with Idiopathic Pulmonary Fibrosis

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To determine the efficacy (as measured by pulmonary function) and safety of CNTO 888 in subjects with IPF.

Critère d'inclusion

  • Idiopathic Pulmonary Fibrosis (IPF)

Liens